Ironwood Pharmaceuticals, Inc.IRWDNASDAQ

Revenue (LTM)

$296M

-15.7% YoY

Net Income (LTM)

$24M

+2629.2% YoY

Free Cash Flow

$127M

Revenue CAGR (5Y)

-5.3%

Marginsimproving

FCF$0.1B

Profitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	414	411↓0.8%	443↑7.8%	351↓20.6%	296↓15.7%
Gross Profit	343	409↑19.2%	437↑6.7%	344↓21.2%	294↓14.4%
Operating Income	232	250↑7.8%	-945↓477.7%	93↑109.8%	119↑27.5%
Net Income	528	175↓66.9%	-1,002↓672.5%	1↑100.1%	24↑2629.2%
EBITDA	234	261↑11.9%	197↓24.5%	98↓50.5%	105↑7.1%
EPS Diluted	3.21	0.96↓70.1%	-6.45↓771.9%	0.01↑100.1%	0.15↑2627.3%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	620	656↑5.8%	92↓86.0%	89↓3.9%	215↑143.3%
Total Current Assets	745	781↑4.8%	233↓70.1%	182↓21.8%	274↑50.3%
Total Assets	1,127	1,101↓2.3%	471↓57.2%	351↓25.5%	397↑13.1%
Total Current Liabilities	162	26↓84.2%	276↑981.7%	39↓85.9%	242↑523.5%
Total Liabilities	521	448↓14.0%	817↑82.4%	652↓20.2%	659↑1.0%
Total Equity	606	652↑7.7%	-346↓153.1%	-301↑13.0%	-262↑13.1%
Total Debt	476	416↓12.6%	716↑72.0%	599↓16.2%	598↓0.3%
Net Debt	-144	-240↓66.5%	623↑359.4%	511↓18.0%	382↓25.2%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	262	274↑4.5%	183↓33.0%	104↓43.5%	127↑22.7%
Capital Expenditure	-0	-0↑48.7%	-0↓100.7%	-0↑48.0%	-0↑76.1%
Free Cash Flow	262	274↑4.6%	183↓33.1%	103↓43.5%	127↑22.8%
Stock-Based Comp	22	27↑21.4%	32↑18.3%	30↓6.7%	17↓42.2%
Net Change in Cash	257	36↓86.0%	-566↓1668.4%	-4↑99.4%	127↑3629.8%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance